期刊文献+

Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children 被引量:18

Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children
原文传递
导出
摘要 Background Airway remodeling is the specific pathological characteristics of asthma, which is related to the clinical symptoms, pulmonary function, and airway hyperreactivity. This study aimed at exploring the effects of dermatophagoides pteronyssinus allergen-specific immunotherapy (SIT) on the serum interleukin (IL)-13 and pulmonary functions in asthmatic children. Methods Fifty-eight pediatric asthma patients allergic to dust mite participated in this study. Thirty-five children received SIT with a standardized dermatophgoides pteronyssinus extract for one year (SIT group), and the other 23 children treated with inhaled corticosteroids (ICS group) according to the Global Initiative for Asthma (GINA) for one year. Serum levels of IL-13, IL-4 and interferon (IFN)-γ were examined and the pulmonary functions were checked before and after the treatment. Results After the treatment, the number of emergency visiting for asthma attack in SIT group was significantly less than that in ICS group. The serum levels of IL-4 and IL-13 were clearly reduced, IFN-γ and the ratio of IFN-γ/IL-4 were significantly increased, the pulmonary functions (forced vital capacity (FVC), forced expiratory volume in one second percentage (FEV1%) and peak expiratory flow percentage (PEF%) were significantly improved in the SIT group. Meanwhile, IFN-γ and the ratio of IFN-γ/IL-4 were greatly increased, but serum levels of IL-4 and IL-13 had less changes, the pulmonary functions (FVC, FEV1% and PEF%) were poorly improved in ICS group. The basic pulmonary functions in both groups were at the same level, which had made more improvement in SIT group than in ICS group one year later. Conclusions One year of dermatophagoides pteronyssinus SIT can significantly reduce the frequencies of emergency visiting for asthma attack and improve the pulmonary functions of children with allergic asthma, and that is attributed to SIT, which can reduce the levels of IL-4 and IL-13 and regulate the imbalance of the Th1/Th2 cells in asthmatic children. All of these might be effective in preventing the asthmatic airway from remodeling. Background Airway remodeling is the specific pathological characteristics of asthma, which is related to the clinical symptoms, pulmonary function, and airway hyperreactivity. This study aimed at exploring the effects of dermatophagoides pteronyssinus allergen-specific immunotherapy (SIT) on the serum interleukin (IL)-13 and pulmonary functions in asthmatic children. Methods Fifty-eight pediatric asthma patients allergic to dust mite participated in this study. Thirty-five children received SIT with a standardized dermatophgoides pteronyssinus extract for one year (SIT group), and the other 23 children treated with inhaled corticosteroids (ICS group) according to the Global Initiative for Asthma (GINA) for one year. Serum levels of IL-13, IL-4 and interferon (IFN)-γ were examined and the pulmonary functions were checked before and after the treatment. Results After the treatment, the number of emergency visiting for asthma attack in SIT group was significantly less than that in ICS group. The serum levels of IL-4 and IL-13 were clearly reduced, IFN-γ and the ratio of IFN-γ/IL-4 were significantly increased, the pulmonary functions (forced vital capacity (FVC), forced expiratory volume in one second percentage (FEV1%) and peak expiratory flow percentage (PEF%) were significantly improved in the SIT group. Meanwhile, IFN-γ and the ratio of IFN-γ/IL-4 were greatly increased, but serum levels of IL-4 and IL-13 had less changes, the pulmonary functions (FVC, FEV1% and PEF%) were poorly improved in ICS group. The basic pulmonary functions in both groups were at the same level, which had made more improvement in SIT group than in ICS group one year later. Conclusions One year of dermatophagoides pteronyssinus SIT can significantly reduce the frequencies of emergency visiting for asthma attack and improve the pulmonary functions of children with allergic asthma, and that is attributed to SIT, which can reduce the levels of IL-4 and IL-13 and regulate the imbalance of the Th1/Th2 cells in asthmatic children. All of these might be effective in preventing the asthmatic airway from remodeling.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第10期1157-1161,共5页 中华医学杂志(英文版)
关键词 IMMUNOTHERAPY bronchial asthma INTERLEUKIN-13 pulmonary function tests CHILDREN immunotherapy bronchial asthma interleukin-13 pulmonary function tests children
作者简介 Corresponctence to: Dr. JI Jing-zhi, Department of Pediatrics, Third Hospital Affiliated to Sun Yat-sen University, Guangzhou, Guangdong 510630, China (Tel: 86-13503089485. Email: jijingzhi@ sina.com)
  • 相关文献

参考文献5

二级参考文献37

  • 1SHENHua-hao.Eosinophil: central mediator of allergic asthma?[J].Chinese Medical Journal,2005(1):4-5. 被引量:5
  • 2XIEZheng-fu SHIHuan-zhong QINXue-jun KANGLan-fu HUANGChun-ping CHENYi-qiang.Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance[J].Chinese Medical Journal,2005(1):6-11. 被引量:5
  • 3Position paper:Immunotherapy.(EAACI) The European Academy of Allergology and Clinical Immunology.Allergy,1993,48 (14 Suppl):7-35.
  • 4Hogg JC,James AL,Pare PD.Evidence for inflammation in asthma.Am Rev Respir Dis,1991,143(3 Pt 2):S39-S42.
  • 5Bousquet J,Hejjaoui A,Clauzel AM,et al.Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract.Ⅱ.Prediction of efficacy of immunotherapy.J Allergy Clin Immunol,1988,82:971-977.
  • 6Yan K,Salome C,Woolcock AJ.Rapid method for measurement of bronchial responsiveness.Thorax,1983,38:760-765.
  • 7Abramson MJ,Puy RM,Weiner JM.Allergen immunotherapy for asthma.Cochrane Database Syst Rev,2003,4:CD001186.
  • 8Adkinson NF Jr,Eggleston PA,Eney D,et al.A controlled trial of immunotherapy for asthma in allergic children.N Engl J Med,1997,336:324 -331.
  • 9Haugaard L,Dahl R,Jacobsen L.A controlled dose-response study of immunotherapy with standardized,partially purified extract of house dust mite:clinical efficacy and side effects.J Allergy Clin Immunol,1993,91:709-722.
  • 10Maestrelli P,Zanolla L,Pozzan M,et al.Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.J Allergy Clin Immunol,2004,113:643-649.

共引文献74

同被引文献104

引证文献18

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部